Single User License
INR 16345
Site License
INR 32690
Corporate User License
INR 49035

Service Tax Additional

select a format
Price

Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Ignyta, Inc. (RXDX)-Medical Equipment-Deals and Alliances Profile

Ignyta, Inc. (RXDX)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME403905D
  • |
  • Pages: 40
  • |
  • November 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

Ignyta Inc (Ignyta), formerly NexDx Inc, is a biotechnology company which discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. It develops products using integrated therapeutic (Rx) and companion diagnostic (Dx) platform. The company's clinical pipeline includes selective tyrosine kinase inhibitor of the TrkA, TrkB, TrkC, ROS1 and ALK protein and a small molecule inhibitor of BRAF, EGFR and RET. Ignyta's other pipeline products encompasses taladegib, a small molecule hedgehog/smoothened antagonist; RXDX-105, a small molecule multikinase inhibitor and RXDX-106, a small molecule, pseudo-irreversible inhibitor of TYRO3, AXL and Mer. The company also develops Trailblaze Diagnostic Programs. Ignytais headquartered in San Diego, California, the US.

Ignyta, Inc. (RXDX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Ignyta, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Ignyta, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6

Ignyta, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Ignyta, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 8

Ignyta, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9

Ignyta, Inc., Medical Equipment, Deal Details 10

Venture Financing 10

NexDx Raises US$5.5 Million In Series B Financing 10

NexDx Raises US$0.5 Million In Series A Financing Round 11

Partnerships 12

NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers 12

Ignyta, Inc.-Key Competitors 13

Key Employees 14

Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Strategy And Business Planning 16

Feb 23, 2016: Ignyta Announces Strategic Positioning that Focuses on Prioritized Pipeline 16

Jan 11, 2016: Ignyta Unveils "5X5" Goal and Announces 2016 Strategic Priorities 17

Financial Announcements 18

Nov 07, 2016: Ignyta Announces Third Quarter 2016 Company Highlights and Financial Results 18

Aug 09, 2016: Ignyta Announces Second Quarter 2016 Company Highlights and Financial Results 19

May 10, 2016: Ignyta Announces First Quarter 2016 Company Highlights and Financial Results 21

Mar 14, 2016: Ignyta Announces 2015 Full Year Company Highlights and Financial Results 24

Nov 09, 2015: Ignyta Announces Third Quarter 2015 Company Highlights and Financial Results 27

Aug 10, 2015: Ignyta Announces Second Quarter 2015 Company Highlights and Financial Results 31

Corporate Communications 34

Jul 05, 2016: Ignyta Appoints Dr. Christian V. Kuhlen as General Counsel 34

Dec 07, 2015: Ignyta Appoints William Mccarthy as Chief Business Officer 35

Sep 17, 2015: Ignyta Appoints Igor Bilinsky as General Manager, Immuno-Oncology and Senior Vice President, Special Operations 36

Sep 02, 2015: Ignyta Appoints Valerie Harding as Senior Vice President, Chemistry, Manufacturing, and Controls 37

Jul 22, 2015: Ignyta Boosts Leadership Capacity with Appointment of Bernard Parker as Chief Commercial Officer 38

Legal and Regulatory 39

Dec 14, 2015: Ignyta Announces Accreditation of its Diagnostic Laboratory by College of American Pathologists 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40

List of Figures

Ignyta, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1

Ignyta, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1

Ignyta, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1

Ignyta, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1

Ignyta, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Ignyta, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 6

Ignyta, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Ignyta, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 8

List of Tables

Ignyta, Inc., Medical Equipment, Key Facts, 2015 1

Ignyta, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1

Ignyta, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Ignyta, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6

Ignyta, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Ignyta, Inc., Deals By Market, 2010 to YTD 2016 8

Ignyta, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9

NexDx Raises US$5.5 Million In Series B Financing 10

NexDx Raises US$0.5 Million In Series A Financing Round 11

NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers 12

Ignyta, Inc., Key Competitors 13

Ignyta, Inc., Key Employees 14

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Ignyta, Inc., Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com